Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV002318697 | SCV000849995 | likely benign | Inborn genetic diseases | 2016-05-14 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Labcorp Genetics |
RCV000958638 | SCV001105505 | likely benign | Hereditary spastic paraplegia 30; Neuropathy, hereditary sensory, type 2C; Intellectual disability, autosomal dominant 9 | 2023-12-04 | criteria provided, single submitter | clinical testing | |
Genetic Services Laboratory, |
RCV001816781 | SCV002065614 | uncertain significance | not specified | 2018-02-10 | criteria provided, single submitter | clinical testing | |
Genome Diagnostics Laboratory, |
RCV001849083 | SCV002104857 | uncertain significance | Hereditary spastic paraplegia | 2020-07-14 | criteria provided, single submitter | clinical testing | |
Ce |
RCV002275153 | SCV002563668 | likely benign | not provided | 2022-07-01 | criteria provided, single submitter | clinical testing | KIF1A: PM2:Supporting, BP4, BP7 |
Prevention |
RCV004737977 | SCV005351295 | likely benign | KIF1A-related disorder | 2024-07-27 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |